NEW YORK (GenomeWeb News) – SeraCare Life Sciences today said that it has acquired Kirkegaard & Perry Laboratories, a supplier of antibodies and reagents for the life science research and diagnostics markets.
Among the products offered by Gaithersburg, Md.-based KPL are reagents kits for protein labeling and purification, nucleic acid labeling, sample preparation, western blotting, immunohistology, and ELISAs. Milford, Mass.-based SeraCare said that the acquisition will expand its portfolio of products and control materials for infectious disease, women's health, and genetic testing in oncology, autoimmune, allergy, and companion diagnostics.
Financial terms of the acquisition were not disclosed, and SeraCare didn't provide revenue figures for privately held KPL.
SeraCare said that it received funding for the acquisition and refinanced existing debt with Mason Capital Funding and BB&T Capital Partners.